Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase

被引：0
|
作者：
Hongchuan Jin
Tobias Sperka
Peter Herrlich
Helen Morrison
机构：
[1] Leibniz Institute of Age Research–Fritz-Lipmann-Institute,Forschungszentrum Karlsruhe
[2] Institute of Toxicology and Genetics,Cancer Center, Department of Clinical Oncology, Prince of Wales Hospital
[3] The Chinese University of Hong Kong,undefined
来源：
Nature | 2006年 / 442卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The phosphatase that activates the Merlin tumour suppressor (also known as neurofibromatosis 2) has been identified. It's a myosin phosphatase that is inhibited by the endogenous inhibitor CPI-17, which is often upregulated in human tumours and may contribute to the development of cancer by inactivating Merlin. Taken together, these findings point to a novel cascade of tumour suppressors whose action can be abolished in at least two ways, by mutation (NF2) or upregulation of the putative novel oncogene, CPI-17.
引用
收藏
页码：576 / 579
页数：3
相关论文
共 50 条
  • [41] TNFα directly suppresses smooth muscle contractility through CPI-17 down-regulation in intestinal inflammation
    Hori, M
    Ozaki, H
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 46P - 46P
  • [42] Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-α and causes motility disorders
    Ohama, Takashi
    Hori, Masatoshi
    Momotani, Eiichi
    Iwakura, Yoichiro
    Guo, Fengling
    Kishi, Hiroko
    Kobayashi, Sei
    Ozaki, Hiroshi
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 292 (05): : G1429 - G1438
  • [43] Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells
    Kim, Jee In
    Urban, Mark
    Young, Garbo D.
    Eto, Masumi
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2012, 303 (01): : C58 - C68
  • [44] Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1β
    Hu, Wenhui
    Mahavadi, Sunila
    Li, Fang
    Murthy, Karnam S.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 293 (06): : C1991 - C2000
  • [45] The Effect of Luteolin on the Modulation of Vascular Contractility via ROCK and CPI-17 Inactivation
    Yoon, Hyuk-Jun
    Kang, Dae Hong
    Jin, Fanxue
    Bang, Joon Seok
    Sohn, Uy Dong
    Je, Hyun Dong
    BIOMOLECULES & THERAPEUTICS, 2023, 31 (02) : 193 - 199
  • [46] Changes in MYPT1, CPI-17 and PP1β contents affect myosin phosphatase activity in hypertrophic smooth muscle
    Bonnevier, J
    Arner, A
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 627A - 627A
  • [47] Solution NMR structure of the myosin phosphatase inhibitor protein CPI-17 shows phosphorylation-induced conformational changes responsible for activation
    Ohki, SY
    Eto, M
    Kariya, E
    Hayano, T
    Hayashi, Y
    Yazawa, M
    Brautigan, D
    Kainosho, M
    JOURNAL OF MOLECULAR BIOLOGY, 2001, 314 (04) : 839 - 849
  • [48] Cpi-17 Associates With Adherens Junction Protein Plakoglobin And Regulates Ec Permeability
    Kasa, A.
    Kim, K. -M.
    Adyshev, D.
    Kolosova, I.
    Verin, A. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [49] Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor
    Eto, M
    Bock, R
    Brautigan, DL
    Linden, DJ
    NEURON, 2002, 36 (06) : 1145 - 1158
  • [50] Phospho-pivot modeling predicts specific interactions of protein phosphatase-1 with a phospho-inhibitor protein CPI-17
    Matsuzawa, F
    Aikawa, S
    Ohki, S
    Eto, M
    JOURNAL OF BIOCHEMISTRY, 2005, 137 (05): : 633 - 641
12345